Profile
Steve J.
King worked as a Principal at Janssen Pharmaceuticals, Inc. and as SVP-Business Development & Project Management at Pharmaceutics International, Inc. He obtained an undergraduate degree from the University of London in 1982.
Former positions of Steve J. King
| Companies | Position | End |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
Pharmaceutics International, Inc.
 Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutics International, Inc. develops and manufactures pharmaceuticals dosage and ingredients. It specializes in solid dispersion development and lipid-or micro/nano-based emulsions. The company was founded in 1994 and is headquartered in Hunt Valley, MD. | Corporate Officer/Principal | - |
Training of Steve J. King
| University of London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Pharmaceutics International, Inc.
Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutics International, Inc. develops and manufactures pharmaceuticals dosage and ingredients. It specializes in solid dispersion development and lipid-or micro/nano-based emulsions. The company was founded in 1994 and is headquartered in Hunt Valley, MD. | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Stock Market
- Insiders
- Steve J. King
